Back

Successful treatment of MR and TR patients​ with differentiated transcatheter technologies.

29 August 2021 (09:23 - 09:29)
Organised by:
Congress Presentation Part of: Transcatheter options for the management of HF patients with MR or TR: the new ESC-HF and ESC/EACTS VHD guidelines Chronic Heart Failure Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Ralph Stephan von Bardeleben

University Medical Center of Mainz, Mainz (Germany)

4 More presentations in this session

Presentation thumbnail
Session opening​.
Professor J. Bax (Leiden, NL)
Video
Presentation thumbnail
Supporting HF treatment through transcatheter valve therapy​.
Professor M. Boehm (Homburg, DE)
Video
Presentation thumbnail
ESC-HF guidelines for management of MR and TR: the update and its clinical implications.
Professor J. Bax (Leiden, NL) Professor M. Boehm (Homburg, DE) Professor R. von Bardeleben (Mainz, DE)
Video
Presentation thumbnail
Session evaluation and key learnings​.
Professor J. Bax (Leiden, NL)
Video

Access the full session

Session thumbnail
Transcatheter options for the management of HF patients with MR or TR: the new ESC-HF and ESC/EACTS VHD guidelines
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 09:23 CET
You may be interested in
thumbnail
Congress Session
Novel approaches to patients with symptomatic tricuspid regurgitation
26 August 2023
thumbnail
Congress Presentation
Transcatheter treatment of severe mitral regurgitation in high surgical risk patients: analysis of clinical and echocardiographic data from a referral center
13 December 2024
thumbnail
Congress Session
Failing valves and beyond
19 May 2025
thumbnail
Congress Presentation
The growing importance of valvular heart diseases management.
3 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources